CHOP experts highlight advances in pediatric cardiology at 2014 AHA Scientific Sessions

November 19, 2014

Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia (CHOP) presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2014 in Chicago. Among many other topics, they investigated using automated external defibrillators in infants, long-term cardiac risk in surgical survivors of the Fontan operations for congenital heart disease, and whether centers that perform more cardiac catheterizations tend to have better outcomes.

Pediatric cardiologist Yoav Dori, M.D., Ph.D., delivered a lecture on fabricating innovative 3-D models of abnormal heart structures in individual patients to assist clinicians in planning complex heart surgery for each patient. Here is his summary of this presentation:

3D Printing of Congenital Heart Disease

As the procedures performed for patients with congenital heart disease (CHD) become more complex, so does the need for better methods and tools for clinicians to understand complex three-dimensional anatomy and spatial relationships. 3-D rapid prototyping is quickly becoming a powerful tool to aid in planning, simulating, and teaching complex corrective CHD procedures. This review discusses the use of 3-D rapid prototyping in patients with CHD.

Children's Hospital clinicians also moderated scientific sessions and participated on expert panels. Below are summaries of some of the research presented at abstract sessions.

Should AEDs Be Used in Infants?

While automated external defibrillators (AEDs) have improved survival rates for out-of-hospital cardiac arrests in many patient subgroups, little is known about the safety and efficacy of AEDs in infants. Joseph Rossano, M.D., and colleagues searched the scientific literature for relevant studies of the use of external defibrillation in infants with pediatric arrhythmias. The data from clinical studies on AED use in infants are limited, with no randomized clinical trials. However, research supports the accuracy of AEDs in recognizing pediatric arrhythmias, and two case reports demonstrated the successful use of AEDs in infants. Dosage studies suggest that further research is needed to determine the most effective defibrillation doses in children. Because the available evidence suggests that AEDs are safe and effective in infants, and because survival is unlikely in the absence of prompt defibrillation, the authors recommend the use of AEDs in infants with suspected cardiac arrest.

Joseph Rossano et al, What is the Evidence for the Use of Automated External Defibrillators in Infants?

Does Volume of Cardiac Caths Correlate with Better Outcomes?

In many types of cardiology procedures, there is an association between higher institutional volume and improved outcomes. Andrew C. Glatz, M.D., and colleagues investigated whether such a relationship occurs in congenital cardiac catheterization. The study team identified all congenital cardiac catheterizations from 2011 to 2013 at 64 institutions in the IMPACT (Improving Pediatric and Adult Congenital Treatment) Registry. Of the 33,825 catheterizations, a major adverse event occurred in 711 cases (2.1%). In unadjusted analysis, the risk of adverse events was lower in centers that perform more catheterizations for congenital heart disease. However, after adjusting for patient- and procedure-level factors, there was no significant association between center volume and outcome. The researchers added that the hospital sample size and low event rate may have limited their ability to detect significant differences. Andrew Glatz et al, Relationship between Hospital Procedure Volume and Complications Following Cardiac Catheterization: A Report from the IMPACT Registry

Fontan Survivors with PA-IVS Remain at Risk for Late Myocardial Infarction

A subset of newborns with the congenital heart condition pulmonary atresia with intact ventricular septum (PA-IVS) are at risk of myocardial infarction (MI) and sudden death because of abnormal coronary circulation. To avoid this, such patients may undergo single ventricle palliation and ultimately the Fontan procedure. Data are lacking, however, on the survivors' risk of long-term myocardial ischemia. Adam Small, M.D., Therese Giglia, M.D., and colleagues performed a retrospective review of CHOP patients who underwent the Fontan procedure for PA-IVS between 1985 and 2013. There were 46 patients who met inclusion criteria for the study, with median follow-up of 3.5 years (range 0-27.9 y) after the Fontan. There were two early deaths after Fontan. Five patients had evidence of late ischemia: 2 had non-fatal MI at 16.9 and 18.8 years post-Fontan and three additional patients had evidence of ischemia on stress test and/or cardiac MRI without clinical evidence of MI. No patient had traditional risk factors for atherosclerotic coronary disease, and there were no late deaths or sustained ventricular tachycardia. Patients with PA-IVS and single-ventricle palliation remain at risk for long-term myocardial ischemia. Further study is needed to define risk factors for ischemic outcomes.

Therese Giglia, Adam Small et al, Late Myocardial Infarction after Fontan in Pulmonary Atresia with Intact Ventricular Septum
-end-
About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. In addition, its unique family-centered care and public service programs have brought the 535-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.

Children's Hospital of Philadelphia

Related Congenital Heart Disease Articles from Brightsurf:

Low risk of COVID-19 infection found among people with congenital heart disease
Results of a retrospective analysis suggest that people born with a heart defect who developed COVID-19 symptoms had a low risk of moderate or severe COVID-19 infection, according to a new article published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

New method for in utero 4D imaging of baby hearts may aid diagnosis of congenital heart disease
Researchers at King's College London have developed a new method for helping detect congenital heart disease of a baby in pregnant mothers using MRI.

Gout treatment may aid patients with congenital heart disease
A drug used to treat gout, probenecid, may improve heart function in individuals with a particular heart defect, according to results from a small pilot study run by a University of Cincinnati researcher.

Stakeholders update newborn screening guidelines for critical congenital heart disease
A distinguished panel of medical experts, state and federal health officials, and congenital heart disease parent advocates published recommended updates to the current American Academy of Pediatrics' protocol for detecting critical congenital heart disease (CCHD) in newborn babies using pulse oximetry.

Congenital heart disease more deadly in low-income countries
Even though mortality from congenital heart disease (CHD) has declined over the last three decades as diagnosis and treatments have advanced, a new study shows that the chances for a child to survive a CHD diagnosis significantly differs based on the country where he or she is born.

Telehealth effectively diagnoses/manages fetal congenital heart disease in rural patients
A recent study of 368 pregnant mothers, led by Bettina Cuneo, MD, director of perinatal cardiology and fetal cardiac telemedicine at Children's Hospital Colorado, found that fetal congenital heart disease (CHD) was correctly identified and successfully managed according to evidence-based risk stratification.

Uncorrected congenital heart disease may lead to increased risks in pregnant women
Pregnant women with congenital heart disease (CHD) who have not had surgery to repair their cardiac condition are more likely to experience cardiac events or maternal death, especially those with certain conditions in emerging countries, according to a study published Oct.

A new framework to study congenital heart defects
In a new study published in the scientific journal Nature, a team of researchers at the Gladstone Institutes, in collaboration with the University of Luxembourg, reveal for the first time the full spectrum of cells that come together to make a heart at the earliest stages of embryo formation.

Risk of cancer among children, young adults with congenital heart disease
National registry data in Sweden were used in this study that assessed the risk of developing cancer in children and young adults with congenital heart disease compared with healthy people in the general population from birth to age 41.

Congenital heart defects vastly increase risk of heart problems later in life
An infant born with a relatively simple heart defect is far more likely to develop heart problems as an adult, researchers at the Stanford University School of Medicine have discovered.

Read More: Congenital Heart Disease News and Congenital Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.